
TTRX P/E Ratio
P/E Ratio as of Oct 28, 2025: -39.65
Average-43.37
Median-39.09
Minimum-69.49
Maximum-31.57
-39.65
The P/E ratio for TTRX is -39.65 as of Oct 28, 2025. This represents a increase of 980.38% compared to its 12-month average P/E ratio of -3.67. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Turn Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Turn Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Turn Therapeutics Inc to industry peers.
Turn Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Turn Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Turn Therapeutics Inc to industry peers.
TTRX P/E Ratio Insights
See Turn Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TTRX
Order type
Buy in
Order amount
Est. shares
0 shares
TTRX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 7, 2025 | $5.83 | -44.03 |
TTRX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -39.65 | — |
FAQs About Turn Therapeutics Inc (TTRX) P/E ratio
The latest P/E ratio of TTRX is -39.65, as of Oct 28, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Turn Therapeutics Inc’s last 12-month average P/E ratio is -3.67, compared to its current P/E ratio of -39.65. This reflects a increase of 980.38%.
Turn Therapeutics Inc’s current P/E ratio of -39.65 is higher than its last 12-month average P/E of -3.67. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Turn Therapeutics Inc’s average P/E ratio over the last 3 years is -1.22. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Turn Therapeutics Inc’s average P/E ratio over the last 5 years is -0.73. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.